XML 33 R18.htm IDEA: XBRL DOCUMENT v3.25.3
(Loss) Earnings Per Common Share
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
(Loss) Earnings Per Common Share
Note 9—(Loss) Earnings Per Common Share

Basic and diluted loss per common share for the three and nine months ended September 30, 2025 and 2024 were calculated as follows:

 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
 (Dollars in millions, except per share amounts, shares in thousands)
Loss (numerator)
Net loss$(621)(148)(1,737)(140)
Net loss applicable to common stock for computing basic loss per common share(621)(148)(1,737)(140)
Net loss as adjusted for purposes of computing diluted loss per common share(621)(148)(1,737)(140)
Shares (denominator):
Weighted-average number of shares:
Outstanding during period1,026,473 1,016,211 1,023,737 1,014,473 
Non-vested restricted stock(30,475)(27,417)(29,800)(27,510)
Weighted average shares outstanding for computing basic loss per common share995,998 988,794 993,937 986,963 
Incremental common shares attributable to dilutive securities:
Shares issuable under convertible securities— — — — 
Shares issuable under incentive compensation plans— — — — 
Number of shares as adjusted for purposes of computing diluted loss per common share995,998 988,794 993,937 986,963 
Basic loss per common share$(0.62)(0.15)(1.75)(0.14)
Diluted loss per common share(1)
$(0.62)(0.15)(1.75)(0.14)
______________________________________________________________________ 
(1)For the three and nine months ended September 30, 2025, we excluded from the calculation of diluted loss per share 11 million and 10 million shares, respectively, potentially issuable under incentive compensation plans or convertible securities, as their effect, if included, would have been anti-dilutive due to our net loss position. For the three and nine months ended September 30, 2024, we excluded from the calculation of diluted loss per share less than 12 million and 5 million shares, respectively, potentially issuable under incentive compensation plans or convertible securities, as their effect, if included, would have been anti-dilutive due to our net loss position.

Our calculation of diluted loss per common share excludes non-vested restricted stock awards that are anti-dilutive based upon the terms of the award. Such shares were 7.6 million and 11.3 million for the three months ended September 30, 2025 and 2024, respectively and 14.7 million and 18.5 million for the nine months ended September 30, 2025 and 2024, respectively.